A single dose of remdesivir will be priced at Tk 5,500, according to officials of the DGDA and the pharmaceutical companies. The pharmacos can initially supply the drug to the hospitals that have been permitted to treat COVID-19. The latest data on the drug showed that it reduced the time of recovery of COVID-19 patients. Remdesivir has been cleared by the US Food and Drug Administration for emergency use in Covid-19 patients — becoming the first medication backed by early clinical data to be made available to fight the novel coronavirus. Beximco Pharmaceuticals Chief Operating Officer Rabbur Reza also said they were expecting to start marketing remdesivir in May.

Source: bd News24 May 08, 2020 21:56 UTC